The Massachusetts Attorney General’s Office has issued 104 indictments to a developer it fears raised the risk of malignant mesothelioma to thousands. The company is accused of illegally demolishing a former elementary school, spreading asbestos dust to a large neighborhood and exposing its own workers to the carcinogenic material at the same time.
Dr. Matthew A. Gubens is a thoracic oncologist at the UCSF Thoracic Surgery and Oncology Clinic at the Helen Diller Family Comprehensive Cancer Center. He specializes in treating patients diagnosed with non-small cell lung cancer, small cell lung cancer, thymoma and thymic carcinoma, and malignant pleural mesothelioma. Dr. Gubens is actively involved in research seeking
Dr. Hitesh Batra is an interventional pulmonologist with special interest in pleural diseases, including malignant pleural mesothelioma. He is Director of the University of Alabama at Birmingham Hospital’s Interventional Pulmonology and Pleural Disease program, the state’s first and only interventional pulmonary program. Partnering with a multidisciplinary team of physicians and other healthcare professionals, he offers
Dr. Julie Renee Brahmer is an international leader in the development of new therapies for the treatment and prevention of lung cancer and malignant mesothelioma. Board certified in Internal Medicine (Medical Oncology), her positions at the Sidney Kimmel Comprehensive Cancer Center include being Co-Director of the Cancer Immunology Program and the Director of Thoracic Oncology.
Dr. Heather Wakelee is a clinical investigator who concentrates her efforts on lung cancer, malignant mesothelioma, and other thoracic malignancies. After years developing research program and being physician lead for Stanford’s thoracic malignancies clinical research group, she took on the role of Deputy Director of the Stanford Cancer Institute. Dr. Wakelee is actively and personally
Dr. David Tom Cooke is Professor and Founding Chief of UC Davis Health Center’s Division of General Thoracic Surgery. He specializes in complex general thoracic surgery and thoracic oncology, with special clinical interests including lung cancers and surgery for malignant mesothelioma. Dr. Cooke is a national leader in robotic thoracic surgery. His skills include minimally
Dr. Jonathan Wesley Riess is a thoracic oncologist at the UC Davis Health Medical Center. As Medical Director of Thoracic Oncology, he relies on advances in diagnostics, targeted therapies, and immunotherapy in the care of patients with malignant mesothelioma, lung cancer, and other thoracic cancers. In addition to his clinical care, he is also actively
Dr. Ravi Salgia is the Professor and Chair of the Department of Medical Oncology & Therapeutics Research at City of Hope in Duarte, California. A board-certified medical oncologist and researcher, he is an expert in the treatment of lung cancer, malignant mesothelioma, and thymic malignancies. Dr. Salgia has over 30 years of award-winning accomplishments in
Dr. Rimner is a radiation oncologist and Scientific Director at the Comprehensive Cancer Center of Freiberg in Baden-Württemberg, Germany. He previously worked with a multidisciplinary team at Memorial Sloan Kettering Cancer Center to identify the best treatment options for patients diagnosed with thoracic cancers. He specializes in a wide range of malignancies, including lung cancer,
Dr. Pennell is a board-certified medical oncologist who has spent more than two decades in clinical practice, specializing in the treatment of thoracic malignancies, including malignant pleural mesothelioma and lung cancer. He now serves as Senior Vice President, Worldwide Head of Medical Affairs, Hematology & Oncology for Bristol Myers Squibb. Prior to this, he was